Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/701
Title: Active surveillance in prostate cancer: a critical review.
Epworth Authors: Murphy, Declan
Other Authors: Zargar, Homayoun
Giannarini, G.
Loeb, Stacy
Dasgupta, Prokar
Ficarra, Vincenzo
Keywords: Prostate Cancer
Prostatic Neoplasm
Active Surveillance
AS
Optimal Risk Stratification and Surveillance
Biomarkers
Australian Prostate Cancer Research Center, Epworth HealthCare, Richmond, Melbourne, Victoria,
​UroRenal & Vascular Clinical Institute, Epworth HealthCare, Richmond, Victoria, Australia
Issue Date: Sep-2015
Publisher: Edizioni Minerva Medica
Citation: Minerva Urol Nefrol. 2015 Sep;67(3):247-61
Abstract: The aim of this paper was to examine the eligibility criteria, surveillance protocols and oncological outcomes of published active surveillance (AS) series. We also assessed the evidence for utility of novel tools for optimal risk stratification and surveillance of men suitable for AS. A non-systematic literature search of the Medline, Embase, and Scopus databases was performed in April 2015 using medical subject headings and free-text protocol. The search was conducted by applying free-text protocol with the following search terms: "active surveillance", "prostate cancer", "prostatic neoplasm", "watchful waiting", "low risk prostate cancer" and "very low risk prostate cancer". The definition of insignificant disease remains debatable as criteria for patient selection vary among studies. Tools for better selection of candidates and monitoring of the disease process have evolved since the conception of AS, including new biomarkers like phi, mpMRI and alternate biopsy strategies. AS is a sound strategy for reducing overtreatment of men with low-risk, and potentially selected men with intermediate-risk prostate cancer and shorter life expectancy, without compromising overall and cancer specific survival. More data are needed on the optimal integration of the new tools on AS paradigms and on the long-term health impact of AS in different populations.
URI: http://hdl.handle.net/11434/701
PubMed URL: http://www.ncbi.nlm.nih.gov/pubmed/26054412
ISSN: 0393-2249
1827-1758
Journal Title: The Italian Journal of Urology and Nephrology
Minerva Urologica e Nefrologica
Type: Journal Article
Affiliated Organisations: Department of Urology, Royal Melbourne Hospital, Melbourne, Victoria, Australia
Urology Unit, Academic Medical Centre Hospital “Santa Maria della Misericordia”, Udine, Italy
Department of Urology and Population Health and the Laura and Isaac Perlmutter Cancer Center, New York University, New York, NY, USA
MRC Centre for Transplantation, NIHR Biomedical Research Centre, King‘s Health Partners, King‘s College London and Department of Urology, Guy‘s Hospital London, UK
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Department of Experimental and Clinical Medical Sciences, University of Udine, Udine, Italy
Type of Clinical Study or Trial: Meta-Analysis
Appears in Collections:Cancer Services
UroRenal, Vascular
Epworth Prostate Centre

Files in This Item:
There are no files associated with this item.


Items in EKB are protected by copyright, with all rights reserved, unless otherwise indicated.